A study of the Incidence of Cytomegalovirus infection and Preemptive Therapy in Kidney Transplant Recipients
-
Published:2022-02-26
Issue:1
Volume:8
Page:
-
ISSN:2413-0516
-
Container-title:Journal of Contemporary Medical Sciences
-
language:
-
Short-container-title:J. Contemp. Med. Sci.
Author:
M Saleem Zana Sidiq,H Abd Kais,Ibrahim Nashwan M.R.,Hussein Nawfal R,Al-Khammas Hasanain MA
Abstract
Objectives: This project aimed to determine the incidence of CVM infection and evaluate the outcome of preemptive treatment.
Methods: This prospective, two centers cohort study included recipients who underwent renal transplant between May 2019-May 2020. The incidence of CMV infection and graft outcomes were studied. All managed with preemptive therapy.
Results: In this study, 134 renal transplant recipients were recruited. Among them, 30/134 (22.4%) patients tested positive for CMV-RTPCR. We studied the impact of age on the CMV-positivity and we found that the age of the doner was associated with CMV-positivity (P= 0.025; OR= 0.923; CI= 0.8584-0.9943). Smoking and gender showed no association with CMV-positivity.
Conclusions: our data suggest that the course of CMV infection is benign with a high success rate of preemptive treatment. Further evaluation for the universal prophylactic plan is needed.
Publisher
Naba'a Al-Hayat Foundation for Medical Sciences and Health Care
Subject
Rehabilitation,Physical Therapy, Sports Therapy and Rehabilitation,General Medicine